The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Golanov A.V.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Banov S.M.
Gamma Knife Center, Moscow, Russia
Il'ialov S.R.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Trunin Yu.Yu.
Burdenko Neurosurgical Institute, Moscow, Russian Federation
Mariashev S.A.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Vetlova E.R.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Osinov I.K.
Gamma Knife Center, Moscow, Russia
Kostiuchenko V.V.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Dalechina A.V.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Durgaryan A.A.
Burdenko Neurosurgical Institute, Moscow, Russia
Overall survival and intracranial relapse in patients with brain metastases after gamma knife radiosurgery alone
Journal: Burdenko's Journal of Neurosurgery. 2016;80(2): 35‑46
Views: 5638
Downloaded: 128
To cite this article:
Golanov AV, Banov SM, Il'ialov SR, et al. . Overall survival and intracranial relapse in patients with brain metastases after gamma knife radiosurgery alone. Burdenko's Journal of Neurosurgery.
2016;80(2):35‑46. (In Russ., In Engl.)
https://doi.org/10.17116/neiro201680235-46
The study purpose was to evaluate the impact of gamma knife radiosurgery (GKRS) alone on the overall survival and rate of intracranial recurrences in brain metastasis patients. Material and methods. Treatment outcomes in 502 patients (211 males and 291 females with 2782 brain metastases (BMs)) were retrospectively reviewed. Most patients (n=142; 28.2%) were diagnosed with breast cancer. Multiple BMs were detected in 259 patients (51.6%). The median of the total tumor volume and ВM number was 5.9 cm3 (0.09―44.5 cm3) and 4 (1―36), respectively. The mean marginal radiation dose was 21 Gy (15―24 Gy). The mean follow-up period was 10.6 months (0.2―47.2 months). Results. The overall survival rate for 12 and 24 months was 37.6 and 19.1%, respectively. The median overall survival after GKRS was 8.6 months (95% confidence interval (CI) 7.0―10.0). Local control of metastatic lesions was achieved in 78.8% of patients. The median local recurrence-free survival was 6.8 months after radiosurgery. The development of new (distant) metastases was observed in 49.5% of patients. The median distant metastasis-free time was 8.8 months. The Karnofsky performance score (KPS) of ≥80 (HR 0.3935, 95% CI 0.2429―0.6376; p=0.0002), BM number of <3 (HR 0.6138, 95% CI 0.3993―0.9943; p=0.0269), and BMs of breast and lung cancers (HR 0.5442, 95% CI 0.3642―0.8071; p=0.0027) are predictors of better survival. In the case of intracranial metastasis recurrence, repeated radiosurgery provides the median overall survival of 19.6 months versus 9.6 months in patients without radiosurgery (HR 0.4026, 95% CI 0.2381―0.6809). Conclusions. Radiosurgical treatment of patients with multiple BMs provides the median overall survival of 8.6 months. A good functional status, non-extensive metastasis of the brain, and radiosensitive morphology of the primary tumor are the predictors of better survival. Repeated radiosurgical treatment for intracranial recurrences provides longer overall survival compared to that in patients without repeated radiosurgical treatment.
Authors:
Golanov A.V.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Banov S.M.
Gamma Knife Center, Moscow, Russia
Il'ialov S.R.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Trunin Yu.Yu.
Burdenko Neurosurgical Institute, Moscow, Russian Federation
Mariashev S.A.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Vetlova E.R.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Osinov I.K.
Gamma Knife Center, Moscow, Russia
Kostiuchenko V.V.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Dalechina A.V.
FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva
Durgaryan A.A.
Burdenko Neurosurgical Institute, Moscow, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.